NSN - 6505-01-290-2997, 6505012902997 of Ceftizoxime Sodium Usp
Aviation Axis stocks NDC00007-3324-01, NDC00007-3324-11, NDC00469-7255-10, NDC57317-0255-10 - Ceftizoxime Sodium Usp made by Glaxosmithkline Holdings Americas, Lypho Med Inc, Astellas Pharma Us Inc with 6505-01-290-2997. Owned and operated by ASAP Semiconductor, we have access to over 2 billion new and after-market parts applicable within the aerospace and defense industries. All our parts are shipped using our premier shipping and supply chain. We offer short lead-times and some of the fastest shipping times in the industry. We are well-equipped to handle any customer situation - including AOG. Submit an RFQ today and expect a response within 15 minutes or less. ASAP - the evolution of purchasing.
Alternative NSN: 6505-01-290-2997 |
Item Name: Ceftizoxime Sodium Usp |
NIIN: 012902997 |
NCB Code: USA (01) |
Manufacturers: Astellas Pharma Us Inc, Glaxosmithkline Holdings Americas, Lypho Med Inc |
Part No | Manufacturer | Item Name | QTY | RFQ |
---|---|---|---|---|
NDC00007-3324-01 | glaxosmithkline holdings americas | ceftizoxime sodium usp | Avl | RFQ |
NDC00007-3324-11 | glaxosmithkline holdings americas | ceftizoxime sodium usp | Avl | RFQ |
NDC00469-7255-10 | lypho med inc | ceftizoxime sodium usp | Avl | RFQ |
NDC00469-7255-10 | astellas pharma us inc | ceftizoxime sodium usp | Avl | RFQ |
NDC57317-0255-10 | astellas pharma us inc | ceftizoxime sodium usp | Avl | RFQ |
Technical Characteristics of NSN 6505012902997
MRC | Criteria | Characteristic |
---|---|---|
CBBL | FEATURES PROVIDED | STERILE |
AGXW | PHYSICAL FORM | POWDER |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 10.000 GRAMS CEFTIZOXIME EQUIVALENT |
CQCT | PRIMARY CONTAINER TYPE | VIAL |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFTIZOXIME SODIUM STERILE USP 100ML VIAL 10S |
CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 MILLILITERS AFTER RECONSTITUTION |
Related NSN List for 6505-01-290-2997, 6505012902997
Send Instant RFQ